No retraction, correction or concern found when last checked on Oct 30, 2026.
Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
Robert N. Kirchdoerfer, Andrew B. Ward
Nature Communications · 2019 · CC BY
Abstract
Recent history is punctuated by the emergence of highly pathogenic coronaviruses such as SARS- and MERS-CoV into human circulation. Upon infecting host cells, coronaviruses assemble a multi-subunit RNA-synthesis complex of viral non-structural proteins (nsp) responsible for the replication and transcription of the viral genome. Here, we present the 3.1 Å resolution structure of the SARS-CoV nsp12 polymerase bound to its essential co-factors, nsp7 and nsp8, using single particle cryo-electron microscopy. nsp12 possesses an architecture common to all viral polymerases as well as a large N-terminal extension containing a kinase-like fold and is bound by two nsp8 co-factors. This structure illuminates the assembly of the coronavirus core RNA-synthesis machinery, provides key insights into nsp12 polymerase catalysis and fidelity and acts as a template for the design of novel antiviral therapeutics.
References 55
- 1.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 2.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 3.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1136/bmj.328.7442.s122-a
- 4.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1038/nature12711
- 5.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1007/3-540-26765-4_3
- 6.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1007/s00705-012-1404-x
- 7.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1073/pnas.1323705111
- 8.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.virusres.2014.10.008
- 9.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1093/nar/gkv838
- 10.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1371/journal.ppat.1006474
- 11.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.virusres.2013.12.004
- 12.
- 13.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1073/pnas.1508686112
- 14.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1038/nsmb999
- 15.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1038/sj.emboj.7601368
- 16.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1093/nar/gkr893
- 17.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1002/wrna.1164
- 18.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1128/jvi.00467-06
- 19.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1073/pnas.0510851103
- 20.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.virusres.2017.01.026
- 21.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1093/nar/gkg277
- 22.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/s0022-2836(02)01033-1
- 23.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1002/j.1460-2075.1989.tb08565.x
- 24.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1073/pnas.1007626107
- 25.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.jmb.2009.04.069
- 26.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1128/jvi.76.7.3482-3492.2002
- 27.
- 28.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1128/jvi.00080-16
- 29.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1128/jvi.06635-11
- 30.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1128/jvi.77.19.10515-10527.2003
- 31.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.virol.2017.10.004
- 32.
- 33.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1007/s12250-016-3726-4
- 34.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.sbi.2009.10.015
- 35.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1093/nar/gkw357
- 36.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1128/jvi.02595-13
- 37.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.cell.2018.08.046
- 38.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.str.2004.01.016
- 39.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1038/nmeth.4461
- 40.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.jsb.2005.03.010
Cited by papers we hold 19
- Structural biology of SARS-CoV-2: open the door for novel therapies · 2022No notice
- The mechanism of RNA capping by SARS-CoV-2 · 2022No notice
- Therapeutic approaches against coronaviruses acute respiratory syndrome · 2021Not checked
- Impact of repurposed drugs on the symptomatic COVID-19 patients · 2021Not checked
- Mechanism of SARS-CoV-2 polymerase stalling by remdesivir · 2021No notice
- The coronavirus proofreading exoribonuclease mediates extensive viral recombination · 2021No notice
- Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis · 2021No notice
- Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP · 2021No notice
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir · 2020No notice
- Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be · 2020No notice
- Structure of the RNA-dependent RNA polymerase from COVID-19 virus · 2020No notice
- A molecular pore spans the double membrane of the coronavirus replication organelle · 2020No notice
- A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping · 2020No notice
- Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors · 2020No notice
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice · 2020No notice
- The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2 · 2020No notice
- Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis · 2020No notice
- Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins · 2020No notice
- The Curious Case of the Nidovirus Exoribonuclease: Its Role in RNA Synthesis and Replication Fidelity · 2019No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.